NCT00038935View on ClinicalTrials.gov

Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Primary Completion Date

February 28, 2003

Study Completion Date

February 28, 2003

Conditions

Hemophilia A

Interventions

DRUG

ReFacto AF

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00038935 - Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A | Biotech Hunter | Biotech Hunter